• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伊朗德黑兰不同年龄组水痘带状疱疹病毒(VZV)的血清流行病学研究

The Seroepidemiology of Varicella Zoster Virus (VZV) in Different Age Groups in Tehran, Iran.

作者信息

Sharifi Zohreh, Emadi Ghanjin Sekyneh

机构信息

Research Center of Iranian Blood Transfusion Organization (IBTO), Tehran, Iran.

出版信息

Iran J Allergy Asthma Immunol. 2005 Jun;4(2):95-8.

PMID:17301429
Abstract

Varicella zoster virus (VZV), the causative agent of chicken pox and shingles, can cause severe systemic infections of the CNS and the respiratory tract in immunocompetent individuals as well as in immunocompromized patients.The aim of this cross-sectional study was to assess the prevalence of antibody Varicella zoster virus in different age groups.The enzyme linked immunosorbent assay (ELISA) method was used to assess the presence of anti -VZV antibody.A total of 635 serum samples were collected. Age specific prevalence of IgG antibody to VZV showed a progressive increase with age in both males and females. The overall seroprevalence rate was 83.6%. Prevalence of antibodies was 59.7% in the age group of less than 10 years, 60.4 % in 10-14 years, 87.5 % in 15-19 years, 88 % in 20-24 years, 89.4 % in 25-29 years and 87.9 % in 30-39 years.The data show that children should be considered as a target group for prevention programs against VZV infection.

摘要

水痘带状疱疹病毒(VZV)是水痘和带状疱疹的病原体,在免疫功能正常的个体以及免疫功能低下的患者中,均可引起中枢神经系统和呼吸道的严重全身性感染。本横断面研究的目的是评估不同年龄组中水痘带状疱疹病毒抗体的流行情况。采用酶联免疫吸附测定(ELISA)法评估抗VZV抗体的存在情况。共收集了635份血清样本。VZV IgG抗体的年龄特异性流行率在男性和女性中均随年龄增长而逐渐升高。总体血清阳性率为83.6%。抗体流行率在小于10岁年龄组为59.7%,10 - 14岁为60.4%,15 - 19岁为87.5%,20 - 24岁为88%,25 - 29岁为89.4%,30 - 39岁为87.9%。数据表明,儿童应被视为预防VZV感染项目的目标群体。

相似文献

1
The Seroepidemiology of Varicella Zoster Virus (VZV) in Different Age Groups in Tehran, Iran.伊朗德黑兰不同年龄组水痘带状疱疹病毒(VZV)的血清流行病学研究
Iran J Allergy Asthma Immunol. 2005 Jun;4(2):95-8.
2
Seroepidemiology of varicella-zoster in Pakistan.巴基斯坦水痘-带状疱疹的血清流行病学
Southeast Asian J Trop Med Public Health. 2000 Dec;31(4):646-9.
3
The prevalence of varicella-zoster virus infection in normal healthy individuals aged above 6 months.6个月以上正常健康个体中水痘-带状疱疹病毒感染的患病率。
J Med Assoc Thai. 2005 Sep;88 Suppl 4:S7-11.
4
[Seroepidemiology of varicella-zoster virus infection measured by the fluorescent antibody to membrane antigen test].[通过膜抗原荧光抗体试验检测水痘-带状疱疹病毒感染的血清流行病学]
Zhonghua Liu Xing Bing Xue Za Zhi. 2009 Apr;30(4):371-5.
5
Seroprevalence of varicella-zoster virus in Korea.韩国水痘-带状疱疹病毒血清流行率。
J Med Virol. 2010 Dec;82(12):2123-6. doi: 10.1002/jmv.21917.
6
Seroprevalence of Varicella-Zoster virus IgG antibodies in Swiss children during the first 16 months of age.瑞士16个月龄以内儿童水痘-带状疱疹病毒IgG抗体血清阳性率
Vaccine. 2006 Apr 12;24(16):3258-60. doi: 10.1016/j.vaccine.2006.01.026. Epub 2006 Jan 19.
7
Seroepidemiology of varicella-zoster virus infection in a cosmopolitan city (Erzurum) in the eastern Turkey.土耳其东部一座国际化城市(埃尔祖鲁姆)水痘-带状疱疹病毒感染的血清流行病学研究
Health Policy. 2005 Apr;72(1):119-24. doi: 10.1016/j.healthpol.2004.03.008.
8
[Seroprevalence of antibodies against measles, rubella, mumps and varicella among school children in Madrid].[马德里学童中麻疹、风疹、腮腺炎和水痘抗体的血清流行率]
An Esp Pediatr. 1999 May;50(5):459-62.
9
Seroprevalence of varicella-zoster virus in Polish population.波兰人群中水痘-带状疱疹病毒的血清流行率。
Przegl Epidemiol. 2009;63(4):495-9.
10
Varicella zoster seroprevalence in children less than 5 years old.5岁以下儿童的水痘带状疱疹血清流行率
J Trop Pediatr. 2005 Jun;51(3):141-4. doi: 10.1093/tropej/fmh102. Epub 2005 Apr 14.

引用本文的文献

1
Varicella-zoster virus seroprevalence among reproductive-age women in Iran: a meta-analysis and implications for targeted immunization.伊朗育龄妇女中水痘-带状疱疹病毒血清流行率:一项荟萃分析及对靶向免疫的启示
BMC Infect Dis. 2025 Aug 18;25(1):1029. doi: 10.1186/s12879-025-11415-2.
2
The clinical and economic burden of varicella in the Middle East: a systematic literature review.中东地区水痘的临床和经济负担:系统文献回顾。
Hum Vaccin Immunother. 2020;16(1):21-32. doi: 10.1080/21645515.2019.1638726. Epub 2019 Sep 3.
3
Epidemiology and factors influencing varicella infections in tropical countries including Sri Lanka.
包括斯里兰卡在内的热带国家水痘感染的流行病学及影响因素。
Virusdisease. 2018 Sep;29(3):277-284. doi: 10.1007/s13337-018-0459-z. Epub 2018 Jul 6.
4
Varicella infection in the Middle East: Prevalence, complications, and vaccination.中东地区的水痘感染:患病率、并发症及疫苗接种情况
J Res Med Sci. 2018 Apr 26;23:19. doi: 10.4103/jrms.JRMS_979_17. eCollection 2018.
5
Cost-effectiveness of Varicella Vaccination Program in Iran.伊朗水痘疫苗接种计划的成本效益
Int J Prev Med. 2017 Dec 5;8:103. doi: 10.4103/ijpvm.IJPVM_295_16. eCollection 2017.
6
Seroprevalence and Risk Factors of Varicella Zoster Infection in Iranian Adolescents: A Multilevel Analysis; The CASPIAN-III Study.伊朗青少年水痘带状疱疹感染的血清流行率及危险因素:一项多层次分析;CASPIAN-III研究
PLoS One. 2016 Jun 29;11(6):e0158398. doi: 10.1371/journal.pone.0158398. eCollection 2016.
7
Seroprevalence of Varicella zoster virus antibody among young women before marriage in Sanandaj, Iran.伊朗萨南达季地区未婚年轻女性中水痘带状疱疹病毒抗体的血清流行率。
Iran J Microbiol. 2016 Apr;8(2):147-52.
8
Sero-Prevalence of Antibodies against Varicella Zoster Virus in Children under Seven-Years Old in 2012 in Tehran, Iran.2012年伊朗德黑兰7岁以下儿童抗水痘带状疱疹病毒抗体的血清流行率
Iran J Public Health. 2014 Nov;43(11):1569-75.
9
Seroprevalence of varicella-zoster virus among pregnant women in two teaching hospitals, Tehran, Iran.伊朗德黑兰两家教学医院孕妇中水痘-带状疱疹病毒血清流行率
Iran J Microbiol. 2014 Feb;6(1):37-40.
10
Varicella immunity in Iran: an age-stratified systematic review and meta-analysis.伊朗的水痘免疫力:一项年龄分层的系统评价与荟萃分析
Iran J Microbiol. 2014 Dec;6(6):372-81.